Quest PharmaTech (TSXV:QPT) Scaled Net Operating Assets : 0.96 (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Quest PharmaTech's operating assets for the quarter that ended in Oct. 2023 was C$67.24 Mil. Quest PharmaTech's operating liabilities for the quarter that ended in Oct. 2023 was C$0.17 Mil. Quest PharmaTech's Total Assets for the quarter that ended in Jul. 2023 was C$69.72 Mil. Therefore, Quest PharmaTech's scaled net operating assets (SNOA) for the quarter that ended in Oct. 2023 was 0.96.

Quest PharmaTech Scaled Net Operating Assets Historical Data

The historical data trend for Quest PharmaTech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Scaled Net Operating Assets Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.61

-2.79

39.38

0.52

0.92

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.99	0.94	0.93	0.88	0.96

Competitive Comparison of Quest PharmaTech's Scaled Net Operating Assets

For the Biotechnology subindustry, Quest PharmaTech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest PharmaTech's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Scaled Net Operating Assets falls into.

Quest PharmaTech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Quest PharmaTech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jan. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jan. 2023 )
=	(Operating Assets (A: Jan. 2023 )	-	Operating Liabilities (A: Jan. 2023 ))	/	Total Assets (A: Jan. 2022 )
=	(83.983	-	0.106)	/	91.029
=	0.92

where

	Operating Assets		(A: Jan. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	84.358	-	0.375
=	83.983

	Operating Liabilities		(A: Jan. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.106	-	0	-	1
=	0.106

Quest PharmaTech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Oct. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Oct. 2023 )
=	(Operating Assets (Q: Oct. 2023 )	-	Operating Liabilities (Q: Oct. 2023 ))	/	Total Assets (Q: Jul. 2023 )
=	(67.243	-	0.165)	/	69.718
=	0.96

where

	Operating Assets		(Q: Oct. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	67.337	-	0.094
=	67.243

	Operating Liabilities		(Q: Oct. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.165	-	0	-	1
=	0.165

Quest PharmaTech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines